Skip to content
DataLookout
Menu

Alkermes clinical trial pipeline

Get alerts when Alkermes's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-14

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor: ALKS 7290 Compared With Placebo · Attention Deficit Hyperactivity Disorder (ALKS 7290-201) Trial sites expanded: 19 → 28 locations Alkermes, Inc.Phase 2 NCT07755410
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-28 NCT07901179 A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to… Phase 2 Recruiting

Active trials by phase

Phase 2
3
Phase 2/3
1
Phase 3
5

Disease areas by active trials

Get alerts when Alkermes's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free